1887

Abstract

Proteins aggregate in several slowly progressive neurodegenerative diseases called ‘proteinopathies’. Studies with cell cultures and transgenic mice overexpressing mutated proteins suggested that aggregates of one protein induced misfolding and aggregation of other proteins as well – a possible common mechanism for some neurodegenerative diseases. However, most proteinopathies are ‘sporadic’, without gene mutation or overexpression. Thus, proteinopathies in WT animals genetically close to humans might be informative. Squirrel monkeys infected with the classical bovine spongiform encephalopathy agent developed an encephalopathy resembling variant Creutzfeldt–Jakob disease with accumulations not only of abnormal prion protein (PrP), but also three other proteins: hyperphosphorylated tau (p-tau), α-synuclein and ubiquitin; β-amyloid protein (Aβ) did not accumulate. Severity of brain lesions correlated with spongiform degeneration. No amyloid was detected. These results suggested that PrP enhanced formation of p-tau and aggregation of α-synuclein and ubiquitin, but not Aβ, providing a new experimental model for neurodegenerative diseases associated with complex proteinopathies.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.062083-0
2014-07-01
2020-01-22
Loading full text...

Full text loading...

/deliver/fulltext/jgv/95/7/1612.html?itemId=/content/journal/jgv/10.1099/vir.0.062083-0&mimeType=html&fmt=ahah

References

  1. Balducci C., Forloni G.. ( 2011; ). APP transgenic mice: their use and limitations. . Neuromolecular Med 13:, 117–137. [CrossRef] [PubMed]
    [Google Scholar]
  2. Ballatore C., Lee V. M. Y., Trojanowski J. Q.. ( 2007; ). Tau-mediated neurodegeneration in Alzheimer’s disease and related disorders. . Nat Rev Neurosci 8:, 663–672. [CrossRef] [PubMed]
    [Google Scholar]
  3. Bautista M. J., Gutiérrez J., Salguero F. J., Fernández de Marco M. M., Romero-Trevejo J. L., Gómez-Villamandos J. C.. ( 2006; ). BSE infection in bovine PrP transgenic mice leads to hyperphosphorylation of tau-protein. . Vet Microbiol 115:, 293–301. [CrossRef] [PubMed]
    [Google Scholar]
  4. Bersano A., Fiorini M., Allaria S., Zanusso G., Fasoli E., Gelati M., Monaco H., Squintani G., Monaco S., Nobile-Orazio E.. ( 2006; ). Detection of CSF 14-3-3 protein in Guillain–Barré syndrome. . Neurology 67:, 2211–2216. [CrossRef] [PubMed]
    [Google Scholar]
  5. Bu B., Klunemann H., Suzuki K., Li J., Bird T., Jin L. W., Vincent I.. ( 2002; ). Niemann–Pick disease type C yields possible clue for why cerebellar neurons do not form neurofibrillary tangles. . Neurobiol Dis 11:, 285–297. [CrossRef] [PubMed]
    [Google Scholar]
  6. Ferrer I., Santpere G., van Leeuwen F. W.. ( 2008; ). Argyrophilic grain disease. . Brain 131:, 1416–1432. [CrossRef] [PubMed]
    [Google Scholar]
  7. Fluharty B. R., Biasini E., Stravalaci M., Sclip A., Diomede L., Balducci C., La Vitola P., Messa M., Colombo L.. & other authors ( 2013; ). An N-terminal fragment of the prion protein binds to amyloid-β oligomers and inhibits their neurotoxicity in vivo . . J Biol Chem 288:, 7857–7866. [CrossRef] [PubMed]
    [Google Scholar]
  8. Forloni G., Sclip A., Borsello T., Balducci C.. ( 2013; ). The neurodegeneration in Alzheimer disease and the prion protein. . Prion 7:, 60–65. [CrossRef] [PubMed]
    [Google Scholar]
  9. Fraser H., Dickinson A. G.. ( 1967; ). Distribution of experimentally induced scrapie lesions in the brain. . Nature 216:, 1310–1311. [CrossRef] [PubMed]
    [Google Scholar]
  10. Furuoka H., Horiuchi M., Yamakawa Y., Sata T.. ( 2011; ). Predominant involvement of the cerebellum in guinea pigs infected with bovine spongiform encephalopathy (BSE). . J Comp Pathol 144:, 269–276. [CrossRef] [PubMed]
    [Google Scholar]
  11. Ghetti B., Tagliavini F., Masters C. L., Beyreuther K., Giaccone G., Verga L., Farlow M. R., Conneally P. M., Dlouhy S. R.. & other authors ( 1989; ). Gerstmann–Sträussler–Scheinker disease. II. Neurofibrillary tangles and plaques with PrP-amyloid coexist in an affected family. . Neurology 39:, 1453–1461. [CrossRef] [PubMed]
    [Google Scholar]
  12. Ghetti B., Piccardo P., Frangione B., Bugiani O., Giaccone G., Young K., Prelli F., Farlow M. R., Dlouhy S. R., Tagliavini F.. ( 1996a; ). Prion protein amyloidosis. . Brain Pathol 6:, 127–145. [CrossRef] [PubMed]
    [Google Scholar]
  13. Ghetti B., Piccardo P., Spillantini M. G., Ichimiya Y., Porro M., Perini F., Kitamoto T., Tateishi J., Seiler C.. & other authors ( 1996b; ). Vascular variant of prion protein cerebral amyloidosis with tau-positive neurofibrillary tangles: the phenotype of the stop codon 145 mutation in PRNP. . Proc Natl Acad Sci U S A 93:, 744–748. [CrossRef] [PubMed]
    [Google Scholar]
  14. Giaccone G., Mangieri M., Capobianco R., Limido L., Hauw J. J., Haïk S., Fociani P., Bugiani O., Tagliavini F.. ( 2008; ). Tauopathy in human and experimental variant Creutzfeldt–Jakob disease. . Neurobiol Aging 29:, 1864–1873. [CrossRef] [PubMed]
    [Google Scholar]
  15. Giasson B. I., Forman M. S., Higuchi M., Golbe L. I., Graves C. L., Kotzbauer P. T., Trojanowski J. Q., Lee V. M. Y.. ( 2003; ). Initiation and synergistic fibrillization of tau and α-synuclein. . Science 300:, 636–640. [CrossRef] [PubMed]
    [Google Scholar]
  16. Gilley J., Adalbert R., Coleman M. P.. ( 2011; ). Modelling early responses to neurodegenerative mutations in mice. . Biochem Soc Trans 39:, 933–938. [CrossRef] [PubMed]
    [Google Scholar]
  17. Goodall C. A., Head M. W., Everington D., Ironside J. W., Knight R. S. G., Green A. J. E.. ( 2006; ). Raised CSF phospho-tau concentrations in variant Creutzfeldt–Jakob disease: diagnostic and pathological implications. . J Neurol Neurosurg Psychiatry 77:, 89–91. [CrossRef] [PubMed]
    [Google Scholar]
  18. Green A. J. E., Andrews M. M., Bishop M. T., McKenzie J. M., McCord Y., Pennington C., Chohan G., Knight R. S.. ( 2010; ). Elevated phosphorylated tau pT-181 in a possible PRNP codon 129 MV vCJD case. . J Neurol Neurosurg Psychiatry 81:, 1408–1409. [CrossRef] [PubMed]
    [Google Scholar]
  19. Hsich G., Kenney K., Gibbs C. J. Jr, Lee K. H., Harrington M. G.. ( 1996; ). The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. . N Engl J Med 335:, 924–930. [CrossRef] [PubMed]
    [Google Scholar]
  20. Ince P. G., Clark B., Holton J., Revesz T., Wharton S. B.. ( 2008; ). Diseases of movement and system degenerations. . In Greenfield’s Neuropathology, pp. 889–981. Edited by Seth L., Louis D. N., Ellison D. W... London:: Hodder Arnold;.
    [Google Scholar]
  21. Jayadev S., Nochlin D., Poorkaj P., Steinbart E. J., Mastrianni J. A., Montine T. J., Ghetti B., Schellenberg G. D., Bird T. D., Leverenz J. B.. ( 2011; ). Familial prion disease with Alzheimer disease-like tau pathology and clinical phenotype. . Ann Neurol 69:, 712–720. [CrossRef] [PubMed]
    [Google Scholar]
  22. Jeffrey M., McGovern G., Chambers E. V., King D., González L., Manson J. C., Ghetti B., Piccardo P., Barron R. M.. ( 2012; ). Mechanism of PrP-amyloid formation in mice without transmissible spongiform encephalopathy. . Brain Pathol 22:, 58–66. [CrossRef] [PubMed]
    [Google Scholar]
  23. Josephs K. A., Ahlskog J. E., Parisi J. E., Boeve B. F., Crum B. A., Giannini C., Petersen R. C.. ( 2009; ). Rapidly progressive neurodegenerative dementias. . Arch Neurol 66:, 201–207. [CrossRef] [PubMed]
    [Google Scholar]
  24. Kirby L., Agarwal S., Graham J. F., Goldmann W., Gill A. C.. ( 2010; ). Inverse correlation of thermal lability and conversion efficiency for five prion protein polymorphic variants. . Biochemistry 49:, 1448–1459. [CrossRef] [PubMed]
    [Google Scholar]
  25. Lasmézas C. I., Deslys J. P., Demaimay R., Adjou K. T., Lamoury F., Dormont D., Robain O., Ironside J., Hauw J. J.. ( 1996; ). BSE transmission to macaques. . Nature 381:, 743–744. [CrossRef] [PubMed]
    [Google Scholar]
  26. Lasmézas C. I., Fournier J. G., Nouvel V., Boe H., Marcé D., Lamoury F., Kopp N., Hauw J. J., Ironside J.. & other authors ( 2001; ). Adaptation of the bovine spongiform encephalopathy agent to primates and comparison with Creutzfeldt–Jakob disease: implications for human health. . Proc Natl Acad Sci U S A 98:, 4142–4147. [CrossRef] [PubMed]
    [Google Scholar]
  27. Lasmézas C. I., Comoy E., Hawkins S., Herzog C., Mouthon F., Konold T., Auvré F., Correia E., Lescoutra-Etchegaray N.. & other authors ( 2005; ). Risk of oral infection with bovine spongiform encephalopathy agent in primates. . Lancet 365:, 781–783. [CrossRef] [PubMed]
    [Google Scholar]
  28. Lowe J., Mirra S. S., Hyman B. T., Dickson D. W.. ( 2008; ). Ageing and dementia. . In Greenfield’s Neuropathology, pp. 1031–1121. Edited by Seth L., Louis D. N., Ellison D. W... London:: Hodder Arnold;.
    [Google Scholar]
  29. Ludolph A. C., Kassubek J., Landwehrmeyer B. G., Mandelkow E., Mandelkow E. M., Burn D. J., Caparros-Lefebvre D., Frey K. A., de Yebenes J. G.. & other authors ( 2009; ). Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options. . Eur J Neurol 16:, 297–309. [CrossRef] [PubMed]
    [Google Scholar]
  30. Nath A., Sammalkorpi M., DeWitt D. C., Trexler A. J., Elbaum-Garfinkle S., O’Hern C. S., Rhoades E.. ( 2012; ). The conformational ensembles of α-synuclein and tau: combining single-molecule FRET and simulations. . Biophys J 103:, 1940–1949. [CrossRef] [PubMed]
    [Google Scholar]
  31. Nygaard H. B., Strittmatter S. M.. ( 2009; ). Cellular prion protein mediates the toxicity of beta-amyloid oligomers: implications for Alzheimer disease. . Arch Neurol 66:, 1325–1328. [CrossRef] [PubMed]
    [Google Scholar]
  32. Piccardo P., Cervenakova L., Vasilyeva I., Yakovleva O., Bacik I., Cervenak J., McKenzie C., Kurillova L., Gregori L.. & other authors ( 2011; ). Candidate cell substrates, vaccine production, and transmissible spongiform encephalopathies. . Emerg Infect Dis 17:, 2262–2269. [CrossRef] [PubMed]
    [Google Scholar]
  33. Piccardo P., Cervenak J., Cervenakova L., Yakovleva O., Vasilyeva I., McKenzie C., Gregori L., Pomeroy K., Seuberlich T., Asher D. M.. ( 2012; ). Squirrel monkeys (Saimiri sciureus) infected with the agent of bovine spongiform encephalopathy develop tau pathology. . J Comp Pathol 147:, 84–93. [CrossRef] [PubMed]
    [Google Scholar]
  34. Prusiner S. B.. ( 1982; ). Novel proteinaceous infectious particles cause scrapie. . Science 216:, 136–144. [CrossRef] [PubMed]
    [Google Scholar]
  35. Reiniger L., Lukic A., Linehan J., Rudge P., Collinge J., Mead S., Brandner S.. ( 2011; ). Tau, prions and Aβ: the triad of neurodegeneration. . Acta Neuropathol 121:, 5–20. [CrossRef] [PubMed]
    [Google Scholar]
  36. Sepulveda-Falla D., Matschke J., Bernreuther C., Hagel C., Puig B., Villegas A., Garcia G., Zea J., Gomez-Mancilla B.. & other authors ( 2011; ). Deposition of hyperphosphorylated tau in cerebellum of PS1 E280A Alzheimer’s disease. . Brain Pathol 21:, 452–463. [CrossRef] [PubMed]
    [Google Scholar]
  37. Shimizu S., Hoshi K., Muramoto T., Homma M., Ironside J. W., Kuzuhara S., Sato T., Yamamoto T., Kitamoto T.. ( 1999; ). Creutzfeldt–Jakob disease with florid-type plaques after cadaveric dura mater grafting. . Arch Neurol 56:, 357–362. [CrossRef] [PubMed]
    [Google Scholar]
  38. Tagliavini F., Giaccone G., Prelli F., Verga L., Porro M., Trojanowski J. Q., Farlow M. R., Frangione B., Ghetti B., Bugiani O.. ( 1993; ). A68 is a component of paired helical filaments of Gerstmann–Sträussler–Scheinker disease, Indiana kindred. . Brain Res 616:, 325–329. [CrossRef] [PubMed]
    [Google Scholar]
  39. Togo T., Sahara N., Yen S. H., Cookson N., Ishizawa T., Hutton M., de Silva R., Lees A., Dickson D. W.. ( 2002; ). Argyrophilic grain disease is a sporadic 4-repeat tauopathy. . J Neuropathol Exp Neurol 61:, 547–556.[PubMed]
    [Google Scholar]
  40. Tokutake T., Kasuga K., Yajima R., Sekine Y., Tezuka T., Nishizawa M., Ikeuchi T.. ( 2012; ). Hyperphosphorylation of Tau induced by naturally secreted amyloid-β at nanomolar concentrations is modulated by insulin-dependent Akt-GSK3β signaling pathway. . J Biol Chem 287:, 35222–35233. [CrossRef] [PubMed]
    [Google Scholar]
  41. Vlad C., Iurascu M. I., Slamnoiu S., Hengerer B., Przybylski M.. ( 2012; ). Characterization of oligomerization-aggregation products of neurodegenerative target proteins by ion mobility mass spectrometry. . Methods Mol Biol 896:, 399–412.[PubMed]
    [Google Scholar]
  42. Walker L. C., Masters C., Beyreuther K., Price D. L.. ( 1990; ). Amyloid in the brains of aged squirrel monkeys. . Acta Neuropathol 80:, 381–387. [CrossRef] [PubMed]
    [Google Scholar]
  43. Wang X. F., Dong C. F., Zhang J., Wan Y. Z., Li F., Huang Y. X., Han L., Shan B., Gao C.. & other authors ( 2008; ). Human tau protein forms complex with PrP and some GSS- and fCJD-related PrP mutants possess stronger binding activities with tau in vitro . . Mol Cell Biochem 310:, 49–55. [CrossRef] [PubMed]
    [Google Scholar]
  44. Wells G. A., Scott A. C., Johnson C. T., Gunning R. F., Hancock R. D., Jeffrey M., Dawson M., Bradley R.. ( 1987; ). A novel progressive spongiform encephalopathy in cattle. . Vet Rec 121:, 419–420. [CrossRef] [PubMed]
    [Google Scholar]
  45. Will R. G., Ironside J. W., Zeidler M., Estibeiro K., Cousens S. N., Smith P. G., Alperovitch A., Poser S., Pocchiari M., Hofman A.. ( 1996; ). A new variant of Creutzfeldt–Jakob disease in the UK. . Lancet 347:, 921–925. [CrossRef] [PubMed]
    [Google Scholar]
  46. Williams L., Brown P., Ironside J., Gibson S., Will R., Ritchie D., Kreil T. R., Abee C.. ( 2007; ). Clinical, neuropathological and immunohistochemical features of sporadic and variant forms of Creutzfeldt–Jakob disease in the squirrel monkey (Saimiri sciureus). . J Gen Virol 88:, 688–695. [CrossRef] [PubMed]
    [Google Scholar]
  47. Wittmann C. W., Wszolek M. F., Shulman J. M., Salvaterra P. M., Lewis J., Hutton M., Feany M. B.. ( 2001; ). Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles. . Science 293:, 711–714. [CrossRef] [PubMed]
    [Google Scholar]
  48. Zanusso G., Fiorini M., Farinazzo A., Gelati M., Benedetti M. D., Ferrari S., Dalla Libera A., Capaldi S., Monaco H. L.. & other authors ( 2005; ). Phosphorylated 14-3-3zeta protein in the CSF of neuroleptic-treated patients. . Neurology 64:, 1618–1620. [CrossRef] [PubMed]
    [Google Scholar]
  49. Zanusso G., Fiorini M., Ferrari S., Gajofatto A., Cagnin A., Galassi A., Richelli S., Monaco S.. ( 2011; ). Cerebrospinal fluid markers in sporadic Creutzfeldt–Jakob disease. . Int J Mol Sci 12:, 6281–6292. [CrossRef] [PubMed]
    [Google Scholar]
  50. Zhou M., Ottenberg G., Sferrazza G. F., Lasmézas C. I.. ( 2012; ). Highly neurotoxic monomeric α-helical prion protein. . Proc Natl Acad Sci U S A 109:, 3113–3118. [CrossRef] [PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.062083-0
Loading
/content/journal/jgv/10.1099/vir.0.062083-0
Loading

Data & Media loading...

Most cited articles

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error